New Advances in Radiopharmaceuticals and Radiotherapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (20 December 2025) | Viewed by 4881
Special Issue Editor
Special Issue Information
Dear Colleagues,
Radiopharmaceuticals and radiotherapy are not new terms in the medical field. However, these areas have gained increasing attention due to advancements in scanning technologies for targeted antibodies, peptides, and small molecules over the past two decades. These developments have opened up opportunities for creating targeted radiopharmaceuticals for precise radiotherapy. This special issue focuses on recent progress in radiopharmaceuticals and radiotherapy. Welcome research from the molecular designs, mechanisms of radiopharmaceuticals and radiotherapy, as well as research from fields such as positron emission tomography (PET), single photon emission computed tomography (SPECT), Boron Neutron Capture Therapy (BNCT), and radiosensitizers, including those based on 67Cu, 177Lu, 131I, 225Ac, 212Pb and 211At. The combinations of abovementioned fileds are extremely attractive. We also encourage submissions on other radiopharmaceuticals and radiotherapy for this special issue.
Dr. Feifei An
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- positron emission tomography
- single photon emission computed tomography
- boron neutron capture therapy
- alfa-particle
- radiopharmaceutical
- radiotherapy
- radiosensitizer
- Cu-67
- Lu-177
- I-131
- Ac-225
- Pb-212
- At-211
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
